| Details |
| Disease Name | Multiple Sclerosis, Relapsing-Remitting |
| Nocoding RNA Name | hsa-miR-2117 |
| Expression Pattern | down-regulated |
| Species | Homo sapiens |
| Detection Methods | microarray etc. |
| Target | N/A |
| Tissue | blood |
| Treatment | natalizumab |
| PubMed ID | 25642434 |
| Year | 2015 |
| Detail Description | blood samples of 17 patients with RR-MS intraindividually before natalizumab administration and after at least 1 year of continuous treatment. This analysis suggested that 14 miRNAs were regulated by natalizumab therapy. Of these, eight were upregulated after natalizumab (miR-18a, miR-29a, miR-20b, miR-103, miR-532-5p, miR-24, miR-342-3p, and miR-7-1*), and six miRNAs were downregulated (miR-411*, let-7d*, miR-380*, miR-2117, miR-2116*, and miR-1237). |
NSDNA: The Nervous System Disease NcRNAome Atlas
Contact wanglh211@163.com for inquiries and feedback
© All right reserved 2016